Accepted at 10:59 a.m. Oct, 09, 2024 by Ahmed7
Bulk Suggestion Bulk ID: mohannadkh10/10.09.24-07:55AM
Author: mohannadkh10
Related Note: 1485736691289 1
Rationale for change

The question asked about the prevalence in July 31 (which basically is the number of active cases on this date)

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#UWorld::Step::14853
#AK_Step1_v12::#UWorld::Step::12854 #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Bootcamp::Biostatistics::03_Risk_Quantification::02_Interpreting_Prevalence_and_Incidence #AK_Step1_v12::#UWorld::COMLEX::27075 #AK_Step1_v12::#UWorld::Step::19517 #AK_Step1_v12::#UWorld::COMLEX::25857 #AK_Step2_v12::#UWorld::Step::4172 #AK_Step2_v12::#FirstAid::04_Epidemiology::01_Assessment_of_Disease_Frequency::01_Assessment_of_Disease_Frequency #AK_Step1_v12::#FirstAid::06_Public_Health::01_Epidemiology_and_Biostatistics::12_Incidence_vs_prevalence::*Prevalence::Basics #AK_Step1_v12::#UWorld::Step::1187 #AK_Step2_v12::#Subjects::Epidemiology_&_Social_Sciences::Biostats::Sensitivity_Specificity_PPV_NPV #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Public_Health_Sciences::Epidemiology_&_Biostats #AK_Step1_v12::^Systems::Biostats #AK_Step1_v12::#Physeo::04_Biostatistics::01_Biostatistics::08_Incidence,_Prevalence_&_Likelihood_Ratios #AK_Step2_v12::#NBME::Form09 #AK_Step1_v12::#UWorld::COMLEX::24298 #AK_Step1_v12::#B&B::05_Biostats/Epi::02_Epidemiology::03_Sensitivity_and_Specificity #AK_Step1_v12::#UWorld::COMLEX::24282 #AK_Step1_v12::#UWorld::Step::1171 #AK_Step1_v12::#Bootcamp::Biostatistics::01_Research_Study_Designs::02_Descriptive_Studies #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#NBME::Form14::Section_3 #AK_Step2_v12::#UWorld::COMLEX::100961 #AK_Step1_v12::#Bootcamp::Biostatistics::03_Risk_Quantification::01_Morbidity_Frequency_Measures #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#B&B::05_Epidemiology::01_General::07_Sensitivity_and_Specificity #AK_Step2_v12::#AMBOSS::Bu0zt3